MESO SCALE DIAGNOSTICS

Rockville, United States Founded: 1995 • Age: 31 yrs
Assay kits and diagnostic instruments are developed and provided.

About MESO SCALE DIAGNOSTICS

MESO SCALE DIAGNOSTICS is a company based in Rockville (United States) founded in 1995. The company has 685 employees. MESO SCALE DIAGNOSTICS operates in a competitive market with competitors including Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.

  • Headquarter Rockville, United States
  • Employees 685
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website mesoscale.com
  • Social LinkedIn
  • Legal Name Meso Scale Diagnostics, Llc
Key Metrics
  • Latest Funding Round
    $2.12M (USD), Grant

    Sep 2022

  • Investors
    HHS

    & 1 more

  • Employee Count
    685

Funding Insights of MESO SCALE DIAGNOSTICS

  • Total Rounds 12
  • Last Round Grant β€” $2.12M
  • First Round $129,673

    (Mar 2008)

  • Investors Count 2

Latest 10 of 12 funding rounds of MESO SCALE DIAGNOSTICS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2022$2.12MGrant––
Sep 2014$297,840Grant––
Sep 2012$784,428Grant––
Mar 2011$1.33MGrant––
Sep 2010$3.29MGrant––
Aug 2008$199,257Grant––
Jun 2008$199,257Grant––
Jun 2008$245,511Grant––
Jun 2008$245,511Grant––
May 2008$1.33MGrant––
Valuation history

2 investors in total: 2 institutional.

Investors in MESO SCALE DIAGNOSTICS

MESO SCALE DIAGNOSTICS has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Military Health.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Administers health care and support for military personnel and operations.
–health.milFalls Church, United States
Premium access

Investor details for MESO SCALE DIAGNOSTICS

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of MESO SCALE DIAGNOSTICS

12 people are tracked at MESO SCALE DIAGNOSTICS (11 in leadership, 1 in team); the tracked headcount is 685.

NameRoleGroup
Pankaj Oberoi
Exec. Vice President, Proteomics TechnologyLeadership
Alan Kishbaugh
Vice President, OperationsLeadership
Jonathan Klein-Evans
Vice President And General CounselLeadership
Christopher Hart
Vice President, It/isLeadership
James Wilbur
Chief Commercial Officer (cco)Leadership
William Dall'Acqua
Executive DirectorLeadership
Jacob Wohlstadter
President & CEOLeadership
Thomas Sanderson
Vice President Of Human ResourcesLeadership
Lillian Quintero
Vice President, Compliance & Bioanalytical TestingLeadership
Matt Revitt
Managing Director, Strategic SalesLeadership
Joseph Amico Sr., Cpe
Senior Director Facilities ManagementLeadership
Travis Wohlers
Associate General Counsel, IP And TransactionsTeam
Premium access

Complete people profiles for MESO SCALE DIAGNOSTICS

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of MESO SCALE DIAGNOSTICS

3 dated milestones of MESO SCALE DIAGNOSTICS across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded MESO SCALE DIAGNOSTICS is founded.
  2. Funding First funding round of $130K.
  3. Funding Latest funding round, Grant, of $2.1M.

Competitors of MESO SCALE DIAGNOSTICS

MESO SCALE DIAGNOSTICS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bio-rad.com1952Hercules, United States–10
Portfolio of products and services for life science research and clinical diagnostic markets
thermofisher.com1956Waltham, United States–75,000
Electron microscopy services and microanalysis instruments are provided.
siemens-healthineers.com1847Erlangen, Germany–66,000
AI-based medical diagnostics are developed for healthcare applications.
merckgroup.com1668Darmstadt, Germany–922
Merck is engaged in science and technology solutions globally.
quanterix.com2007Cambridge, United States$99.5M141
Assay kits for ultra-sensitive biomarker detection are developed.
biocare.net1997Concord, United States$85M161
Primary antibodies and instruments for immunohistochemistry are manufactured.
biolifesolutions.com1987Bothell, United States–685
Tissue hypothermic storage and cryopreservation freeze media are developed.
apbiocode.com2008Santa Fe Springs, United States$20.29M66
Assay kits and instruments for in vitro diagnostics are developed.
Premium access

Detailed competitors of MESO SCALE DIAGNOSTICS

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MESO SCALE DIAGNOSTICS

The website of MESO SCALE DIAGNOSTICS (mesoscale.com) receives about 55.1K visits a month.

  • Monthly visits
    55.1K

    ▲ 19.5% vs previous month

Similar websites

Websites whose visitors overlap most with MESO SCALE DIAGNOSTICS. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
qiagen.com
100%
458.2K#105,023View details
rndsystems.com
97%
349K#159,292View details
bio-rad.com
93%
665.2K#79,666View details
bostonind.com
bostonind.com
90%
–#1,001,333–
mybiosource.com
90%
–#238,129View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 24 similar websites and full traffic analytics for MESO SCALE DIAGNOSTICS

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 24 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to MESO SCALE DIAGNOSTICS

10 companies that operate in the same segment as MESO SCALE DIAGNOSTICS (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about MESO SCALE DIAGNOSTICS

MESO SCALE DIAGNOSTICS was founded in 1995 and raised its 1st funding round 13 years after it was founded.

MESO SCALE DIAGNOSTICS is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.

MESO SCALE DIAGNOSTICS has 685 employees.

Founded in 1995 in Rockville, United States, the company operates in the biotechnology sector. Assay kits for angiogenesis, vascular functions, bone metabolism, cytokines, chemokines, inflammation, intracellular signaling, and neurodegeneration are developed. Instruments such as the Meso Sector 600 and QuickPlex SQ 120 are offered. Services encompass assay development, biomarker analysis, custom conjugation, and prototype printing.

MESO SCALE DIAGNOSTICS's top competitors include Thermo Fisher Scientific, Biocare Medical and Merck.

MESO SCALE DIAGNOSTICS has 2 investors. Key investors include HHS, and Military Health.

MESO SCALE DIAGNOSTICS operates through Meso Scale Diagnostics, Llc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available